A study to look at how safe different doses of MOXR0916 were for patients with cancer – when combined with one or two other medicines

A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

Cancer
Tumor
Neoplasms
Solid Tumors

Results
Download
Print

Study results

LPS_GO29674_final results_July2020_English (PDF, 0.2 MB)

LPS_GO29674_final results_July2020_French_Belgium (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_French_Canada (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_French_France (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Korean_Korea (PDF, 0.3 MB)

LPS_GO29674_final results_July2020_Spanish_Spain (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Spanish_USA (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Dutch_Belgium (PDF, 0.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to look at how safe different doses of MOXR0916 were for patients with cancer – when combined with one or two other medicines

Study results

LPS_GO29674_final results_July2020_English (PDF, 0.2 MB)

LPS_GO29674_final results_July2020_French_Belgium (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_French_Canada (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_French_France (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Korean_Korea (PDF, 0.3 MB)

LPS_GO29674_final results_July2020_Spanish_Spain (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Spanish_USA (PDF, 0.1 MB)

LPS_GO29674_final results_July2020_Dutch_Belgium (PDF, 0.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study to look at how safe different doses of MOXR0916 were for patients with cancer – when combined with one or two other medicines

For the latest version of this information please go to www.forpatients.roche.com